Mingjin Yan

900 total citations
15 papers, 636 citations indexed

About

Mingjin Yan is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mingjin Yan has authored 15 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Mingjin Yan's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (6 papers). Mingjin Yan is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (6 papers). Mingjin Yan collaborates with scholars based in United States, United Kingdom and France. Mingjin Yan's co-authors include Keying Ye, Andrew Cheng, David V. Sheehan, Atul R. Mahableshwarkar, Paula L. Jacobsen, Joel E. Gallant, Martin S. Rhee, Michael E. Abram, François Raffi and Leszek Bidzan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biometrics.

In The Last Decade

Mingjin Yan

15 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjin Yan United States 10 362 211 186 85 82 15 636
Jennifer Marquie‐Beck United States 14 269 0.7× 441 2.1× 214 1.2× 16 0.2× 131 1.6× 18 699
Taiyi Jiang China 11 145 0.4× 115 0.5× 64 0.3× 7 0.1× 76 0.9× 31 346
Chris Higgs United Kingdom 15 370 1.0× 283 1.3× 91 0.5× 12 0.1× 89 1.1× 35 716
Isabelle Kousignian France 10 194 0.5× 154 0.7× 110 0.6× 8 0.1× 74 0.9× 25 533
R Deutsch United States 7 161 0.4× 241 1.1× 140 0.8× 10 0.1× 178 2.2× 9 537
Patrizia Lorenzini Italy 13 501 1.4× 530 2.5× 202 1.1× 11 0.1× 121 1.5× 49 820
Elisabetta Teti Italy 11 149 0.4× 65 0.3× 54 0.3× 10 0.1× 55 0.7× 38 300
Clifford Lane United States 9 283 0.8× 320 1.5× 65 0.3× 8 0.1× 96 1.2× 13 626
Susan Swindells United States 8 171 0.5× 155 0.7× 75 0.4× 15 0.2× 93 1.1× 11 346
Aurélie Fischer Luxembourg 13 213 0.6× 125 0.6× 13 0.1× 4 0.0× 121 1.5× 33 585

Countries citing papers authored by Mingjin Yan

Since Specialization
Citations

This map shows the geographic impact of Mingjin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjin Yan more than expected).

Fields of papers citing papers by Mingjin Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjin Yan. The network helps show where Mingjin Yan may publish in the future.

Co-authorship network of co-authors of Mingjin Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjin Yan. A scholar is included among the top collaborators of Mingjin Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjin Yan. Mingjin Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mamdani, Hirva, J. Randolph Hecht, Rachel E. Sanborn, et al.. (2024). Abstract CT078: Phase 1 study of SGN-EGFRd2 in solid tumors (SGNEGFRd2-001). Cancer Research. 84(7_Supplement). CT078–CT078. 1 indexed citations
2.
Hollebecque, Antoine, Juanita Lopez, Sarina A. Piha‐Paul, et al.. (2023). SGN-B6A, an integrin beta-6 (ITGB6)-targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors: Updated results from a phase 1 study (SGNB6A-001).. Journal of Clinical Oncology. 41(16_suppl). 3024–3024. 7 indexed citations
3.
Patnaik, Amita, Justin Call, Anna Spreafico, et al.. (2022). Phase 1 study of SGN-PDL1V, a novel, investigational vedotin antibody–drug conjugate directed to PD-L1, in patients with advanced solid tumors (SGNPDL1V-001, trial in progress).. Journal of Clinical Oncology. 40(16_suppl). TPS3154–TPS3154. 3 indexed citations
4.
5.
6.
Raffi, François, Chloe Orkin, Amanda Clarke, et al.. (2017). Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2). 226–231. 60 indexed citations
7.
8.
9.
Huhn, Gregory, Pablo Tebas, Joel E. Gallant, et al.. (2016). A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2). 193–200. 41 indexed citations
10.
Mills, Anthony, Gordon Crofoot, Cheryl McDonald, et al.. (2015). Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(4). 439–445. 121 indexed citations
11.
12.
Bidzan, Leszek, Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, & David V. Sheehan. (2012). Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial. European Neuropsychopharmacology. 22(12). 847–857. 59 indexed citations
13.
Rothschild, Anthony J., Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, & David V. Sheehan. (2012). Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. European Neuropsychopharmacology. 22(12). 858–866. 47 indexed citations
14.
Yan, Mingjin & Keying Ye. (2007). Determining the Number of Clusters Using the Weighted Gap Statistic. Biometrics. 63(4). 1031–1037. 101 indexed citations
15.
Hrubec, Terry C., Mingjin Yan, Keying Ye, Carolyn M. Salafia, & Steven D. Holladay. (2006). Valproic acid‐induced fetal malformations are reduced by maternal immune stimulation with granulocyte‐macrophage colony‐stimulating factor or interferon‐γ. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 288A(12). 1303–1309. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Marquie‐Beck Breakdown of academic impact, for papers by Taiyi Jiang Breakdown of academic impact, for papers by Chris Higgs Breakdown of academic impact, for papers by Isabelle Kousignian Breakdown of academic impact, for papers by R Deutsch Breakdown of academic impact, for papers by Patrizia Lorenzini Breakdown of academic impact, for papers by Elisabetta Teti Breakdown of academic impact, for papers by Clifford Lane Breakdown of academic impact, for papers by Susan Swindells Breakdown of academic impact, for papers by Aurélie Fischer
Rankless by CCL
2026